Trial Profile
Bendamustine Versus Fludarabine as 2nd-line Treatment in Chronic Lymphocytic Leukemia, Stage BINET B+C / RAI II-IV
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 29 Aug 2011
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 29 Aug 2011 NCT record details added to profile and multiple details added
- 05 Nov 2010 New trial record.